# YUPELRI

NDC: 49502-806
Generic name: revefenacin
Labeler / Manufacturer: Viatris Specialty LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: RESPIRATORY (INHALATION)
Marketing started: 20181203

FDA application: NDA210598

## Active ingredients

- REVEFENACIN: 175 ug/3mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"49502-806"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49502-806
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6dfebf04-7c90-436a-9b16-750d3c1ee0a6